Unsplash
On October 2, 2026, NASA officially announced that the ‘Crew-12’ astronauts are preparing to return to Earth in early October, following months of scientific research aboard the International Space Station (ISS). The mission includes NASA’s Jessica Meir and Jack Hathaway, ESA’s Sophie Adenot, and Roscosmos’s Andrey Fedyaev. Their experiments in microgravity are expected to extend beyond space exploration, directly impacting human health on Earth and driving innovation in everyday advanced technologies.
Breakthroughs in Medical Treatments: Advancements in Cancer Drugs and Osteoporosis Research
One of the most notable achievements of Crew-12 on the ISS is in the field of biotechnology and medicine. Using the microgravity environment, the astronauts conducted high-purity protein crystal growth experiments, which are difficult to replicate on Earth. In particular, the ‘ADSEP-PIL-15’ experiment, which focused on crystallizing components of targeted cancer therapies, aimed to improve drug stability and quality. This research is expected to contribute to the development of more effective cancer treatments with fewer side effects on the ground.
Significant progress was also made in bone regeneration research for osteoporosis patients. ESA astronaut Sophie Adenot conducted the ‘Green Bone’ project, testing artificial scaffolds that mimic real bone structures using wood-derived components. Because bone loss occurs rapidly in the near-zero gravity of space, the station provides a unique vantage point to observe how these scaffolds aid bone cell growth. This research is considered a promising new alternative for treating osteoporosis, which affects over 200 million people worldwide. Additionally, an experiment successfully mass-produced clinical-grade hematopoietic stem cells for treating blood disorders like leukemia, drawing significant interest from the medical community.
Microgravity Experiments Driving Everyday Innovation: Quantum Devices and Metal 3D Printing
Research in space is also closely linked to improving the performance of the smartphones and computers we use daily. NASA astronaut Jack Hathaway performed the mission of upgrading equipment in the Cold Atom Lab and observing the quantum mechanical properties of atoms. Because cryogenically cooled atoms can be observed for longer periods in microgravity, they provide key data necessary for developing next-generation quantum computer components and high-efficiency solar cells.
In manufacturing technology, the in-orbit demonstration of a ‘metal 3D printer’ was a standout achievement. The astronauts successfully printed small metal parts inside the station; these components will be returned to Earth for precise comparative analysis of their durability and accuracy against ground-manufactured parts. Once this technology is fully established, future deep-space missions could source necessary parts on-site rather than relying on resupply from Earth. This technology could also be applied to disaster zones or isolated areas on Earth where urgent parts are needed.
Space Medical Technology to Bridge Healthcare Gaps: On-Demand IV Production and Antibiotic Resistance
Technologies designed to bring innovation to regions with inadequate healthcare infrastructure were also validated. A primary example is the ‘IVGEN Mini’ experiment. Typical intravenous (IV) fluids have a short shelf life of about 16 months and are bulky and heavy, which poses significant challenges for long-term space missions or remote medical support. Crew-12 tested a system to manufacture IV fluid on-demand at the station. Once commercialized, this technology could revolutionize the solution to IV supply shortages in disaster areas, military operations, or medically underserved islands.
Furthermore, the astronauts conducted the ‘GEARS’ project to track and analyze the DNA of antibiotic-resistant bacteria that become more resilient in confined environments like spacecraft. By identifying how microorganisms adapt and mutate in microgravity, this research is expected to contribute to new antibiotic and quarantine strategies to combat the growing global threat of antibiotic-resistant superbugs on Earth.
Future Challenges and Unanswered Questions in Expanding Space Territory
The completion of the Crew-12 mission and their return will serve as an important stepping stone for the ‘Artemis’ era, as humanity looks beyond low Earth orbit toward the Moon and Mars. However, many challenges remain before these promising space-based results can be commercialized on Earth. Long-term clinical trials are essential to verify the safety of stem cells or artificial cartilage tissue cultured in space, and the structural integrity of metal 3D-printed parts must undergo rigorous ground analysis to ensure reliability.
The return date, scheduled for early October, remains fluid depending on Earth’s weather conditions and technical variables during atmospheric reentry. Even after the astronauts safely step onto Earth, follow-up research will continue to track the physiological changes as their bodies, exposed to microgravity for months, adapt to Earth’s gravity. The global scientific and industrial communities are focused on their return, eager to see how the scientific clues provided by space will transform human life.
Official Source List: